文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

严重低体温的VA-ECMO治疗管理:现状如何?病例报告与文献综述

Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature.
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2020-04-21
一句话结论近期国际出版物和专家组推荐将VA-ECMO作为治疗严重低体温的金标准疗法;一例46岁患者体温22.4°C伴初始心脏骤停,经VA-ECMO支持后完全康复。

本文报告一例46岁严重低体温患者,体温22.4°C并初始心脏骤停,实施VA-ECMO支持后病情好转,两个月后精神和身体能力完全恢复。结论指出,近期国际出版物和专家组推荐将VA-ECMO作为治疗严重低体温的金标准疗法。两个不同的医学团队尝试识别和重新归类预后因素以构建预测生存评分,并质疑这些评分在临床实践中的效用。生存评分的外部认可需要额外研究,也需要专家进一步思考。

要点

  • 近期国际出版物和专家组推荐将VA-ECMO作为治疗严重低体温的金标准疗法。
  • 一例46岁患者体温22.4°C伴初始心脏骤停,经VA-ECMO支持后病情好转,两个月后完全康复。
  • 两个不同的医学团队尝试识别和重新归类预后因素以构建预测生存评分。
  • 这些生存评分在临床实践中的效用受到质疑。
  • 生存评分的外部认可需要额外研究,也需要专家进一步思考。

适用人群与场景

  • 严重意外性低体温患者
  • 一例46岁患者,体温22.4°C,伴初始心脏骤停

处置流程与药物剂量

  • 对严重低体温患者实施VA-ECMO支持。

红旗征与不能漏的情况

  • 初始心脏骤停。

研究设计与关键结果

  • 病例报告:46岁患者,体温22.4°C,初始心脏骤停,实施VA-ECMO支持后病情好转,两个月后精神和身体能力完全恢复。
  • 两个不同的医学团队尝试识别和重新归类预后因素以构建预测生存评分。
  • 这些生存评分在临床实践中的效用受到质疑。

证据类型、等级与局限

  • 证据类型:病例报告与文献综述。
  • 近期国际出版物和专家组推荐将VA-ECMO作为治疗严重低体温的金标准疗法。
  • 局限:生存评分的外部认可需要额外研究,也需要专家进一步思考。

对床旁实践的改变

  • 近期国际出版物和专家组推荐将VA-ECMO作为治疗严重低体温的金标准疗法。
  • 生存评分在临床实践中的效用受到质疑;根据哪个生存率来决定进行延长复苏和实施VA-ECMO仍存疑问。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severe accidental hypothermia is associated with high morbidity and mortality. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides an efficient rewarming method with complete cardiopulmonary support. The use of VA-ECMO for this indication has greatly improved the vital and functional prognosis of patients.

CASE PRESENTATION: We report a case of a 46-year-old patient who was treated for severe hypothermia with a temperature of 22.4 °C along with initial cardiac arrest, whose progression was favorable after the implementation of VA-ECMO support. Two months after initial cardiac arrest, the patient was reassessed and showed signs of complete recovery with regard to his mental and physical capacities.

CONCLUSIONS: The recent international publications and groups of experts recommend the use of VA ECMO as the gold standard therapy to treat severe hypothermia. Therefore, it seems suitable to update the current knowledge on the topic by analysing the latest international publications. The performance of this technique calls into question ethical and economic factors. Two distinct medical teams tried to identify and regroup prognosis factors in predictive survival scores. They raise the question of the utility of these scores in clinical practice. Indeed, according to which survival rate should we proceed to prolonged resuscitation and implement VA-ECMO? Additional studies will be needed for external approval of these survival scores, and additional reflection by experts will be required.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ledoux A, Saint Leger P. Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature. Scand J Trauma Resusc Emerg Med. 2020. PMID: 32316980. doi:10.1186/s13049-020-00723-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。